TP53 and ovarian cancer: Our data suggest that ovarian cancer metastasis and cisplatin resistance is associated with the differential regulation of the MAPK/PI3K/AKT-mediated ERS and autophagy through the crosstalk of STAT3 and p53/RAS signaling.